Signal persistence and amplification in cancer development and possible, related opportunities for novel therapies

Shea A Ford1, George Blanck2

  • 1Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, United States.

Insights

Cancer research needs new paradigms beyond simple on/off switches. This review explores signal pathway persistence and amplification in cancer, suggesting therapeutic potential for exploiting hyper-activated pathways.

Area of Science:

  • Cancer Biology
  • Molecular Oncology
  • Developmental Biology

Background:

  • Traditional cancer research often uses reductionist approaches (e.g., gene knockouts) to study discreet inputs and outputs.
  • Cancer hallmarks are complex and rarely depend on isolated regulatory processes; instead, regulatory factors impact multiple hallmarks.
  • Existing paradigms may not fully capture the complexity of cancer regulatory networks.

Purpose of the Study:

  • To review mechanisms and effects of signal pathway persistence and amplification in cancer.
  • To explore the relationship between developmental regulatory paradigms and cancer signaling.
  • To investigate the therapeutic potential of exploiting hyper-activated pro-proliferative pathways in cancer.

Main Methods:

  • Literature review focusing on signal pathway persistence and amplification.
  • Analysis of emerging paradigms in cancer research.
  • Exploration of developmental biology principles in cancer contexts.

Main Results:

  • Signal pathway persistence and amplification are emerging as key concepts in cancer research, distinct from simple on/off activation.
  • These persistent and amplified pathways are closely related to developmental regulatory mechanisms.
  • Hyper-activation of pro-proliferative signal pathways presents potential therapeutic targets.

Conclusions:

  • Novel approaches focusing on signal pathway dynamics (persistence, amplification) are crucial for advancing cancer biology.
  • Understanding these dynamic processes, linked to development, offers new insights into cancer hallmarks.
  • Targeting hyper-activated pro-proliferative pathways holds promise for future cancer therapies.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
8.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
8.0K